IDKmonitor® Adalimumab Drug Level ELISA (Health Canada)

Product Specifications

Method: ELISA
Sample Type (Matrix): Serum, EDTA Plasma
Sample Volume: 10 µL
Species: Human
Incubation time: 2h 10m
Standard Range: 4.15-225 ng/ml
Size: 96 wells
Regulatory Status: Health Canada Licensed. Not for sale in the U.S.

Description

The IDKmonitor® Adalimumab Drug Level ELISA is for the determination of the drug level of adalimumab (e.g. HUMIRA®) and quantitatively measures free adalimumab in EDTA plasma and serum.

Health Canada Licensed. For Laboratory Professional Use Only.

Not for sale in the U.S. Please contact us to order or get a quote.

If you are in the U.S., you can purchase the RUO version of the Adalimumab Drug Level ELISA.

Browse our other IDKmonitor® Adalimumab ELISAs.

Test Principle of the IDKmonitor® Adalimumab Drug Level ELISA

The IDKmonitor® Adalimumab Drug Level ELISA is designed to quantitate free adalimumab (therapeutic antibody against TNFα, e. g. HUMIRA®) in EDTA plasma or serum samples.

In the first incubation step, the free adalimumab from the sample is bound to the specific monoclonal anti-adalimumab antibody coated on the plate. To remove all unbound substances, a washing step is carried out. In a further incubation step, a Peroxidase-labeled antibody is added. Tetramethylbenzidine (TMB) is used as a substrate for peroxidase. Finally, an acidic stop solution is added to terminate the reaction.

The color changes from blue to yellow. The intensity of the yellow color is directly proportional to the concentration of free adalimumab in the sample. A dose-response curve of the absorbance unit (optical density, OD) vs. concentration is generated using the values obtained from the standard. The concentrations of free adalimumab in the samples are determined directly from this curve.

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors